FI65631C - Foerfarande foer framstaellning av a-21978-antibiotika - Google Patents

Foerfarande foer framstaellning av a-21978-antibiotika Download PDF

Info

Publication number
FI65631C
FI65631C FI793190A FI793190A FI65631C FI 65631 C FI65631 C FI 65631C FI 793190 A FI793190 A FI 793190A FI 793190 A FI793190 A FI 793190A FI 65631 C FI65631 C FI 65631C
Authority
FI
Finland
Prior art keywords
factor
mixture
salt
factors
asp
Prior art date
Application number
FI793190A
Other languages
English (en)
Finnish (fi)
Other versions
FI65631B (fi
FI793190A (fi
Inventor
Robert L Hamill
Marvin Martin Hoehn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI793190A publication Critical patent/FI793190A/fi
Publication of FI65631B publication Critical patent/FI65631B/fi
Application granted granted Critical
Publication of FI65631C publication Critical patent/FI65631C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein
FI793190A 1978-10-16 1979-10-15 Foerfarande foer framstaellning av a-21978-antibiotika FI65631C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95169578 1978-10-16
US05/951,695 US4208403A (en) 1978-10-16 1978-10-16 A-21978 Antibiotics and process for their production

Publications (3)

Publication Number Publication Date
FI793190A FI793190A (fi) 1980-04-17
FI65631B FI65631B (fi) 1984-02-29
FI65631C true FI65631C (fi) 1984-06-11

Family

ID=25492027

Family Applications (1)

Application Number Title Priority Date Filing Date
FI793190A FI65631C (fi) 1978-10-16 1979-10-15 Foerfarande foer framstaellning av a-21978-antibiotika

Country Status (36)

Country Link
US (1) US4208403A (es)
EP (1) EP0010421B1 (es)
JP (2) JPS5592353A (es)
AR (1) AR221738A1 (es)
AT (1) AT365235B (es)
AU (1) AU531616B2 (es)
BE (1) BE879401A (es)
BG (1) BG41138A3 (es)
CA (1) CA1137900A (es)
CH (1) CH655127A5 (es)
CS (1) CS219259B2 (es)
DD (1) DD146618A5 (es)
DE (1) DE2967701D1 (es)
DK (1) DK148918C (es)
DO (1) DOP1979002809A (es)
EG (1) EG14631A (es)
ES (1) ES485074A1 (es)
FI (1) FI65631C (es)
FR (1) FR2444079A1 (es)
GB (1) GB2031437B (es)
GR (1) GR73146B (es)
GT (1) GT196000041A (es)
HK (1) HK42987A (es)
HU (1) HU180746B (es)
IE (1) IE48564B1 (es)
IL (1) IL58448A (es)
LU (1) LU81794A1 (es)
MY (1) MY8500568A (es)
NZ (1) NZ191822A (es)
PH (1) PH16248A (es)
PL (1) PL122756B1 (es)
PT (1) PT70298A (es)
RO (1) RO77097A (es)
SU (1) SU1071226A3 (es)
YU (1) YU247079A (es)
ZA (1) ZA795435B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) * 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
SU1452484A3 (ru) * 1984-10-09 1989-01-15 Эли Лилли Энд Компани (Фирма) Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С
US4800157A (en) * 1985-09-09 1989-01-24 Eli Lilly And Company Process for producing the A-21978C antibiotics
US4874843A (en) * 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US4994270A (en) * 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5028590A (en) * 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
JP2863934B2 (ja) * 1989-07-24 1999-03-03 塩野義製薬株式会社 抗生物質プラスバシン
US7235651B2 (en) * 2001-12-26 2007-06-26 Cubist Pharmaceuticals, Inc. Genes and proteins involved in the biosynthesis of lipopeptides
CN101165168B (zh) * 2006-10-20 2010-05-12 上海爱普香料有限公司 一株链霉菌及利用其生物转化阿魏酸生产香兰素的方法
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici

Also Published As

Publication number Publication date
IE48564B1 (en) 1985-03-06
FR2444079B1 (es) 1983-08-05
PH16248A (en) 1983-08-16
EP0010421B1 (en) 1990-10-10
ATA669979A (de) 1981-05-15
FR2444079A1 (fr) 1980-07-11
HU180746B (en) 1983-04-29
DK434479A (da) 1980-05-14
JPH0123479B2 (es) 1989-05-02
BG41138A3 (en) 1987-04-15
US4208403A (en) 1980-06-17
ES485074A1 (es) 1980-06-16
PT70298A (en) 1979-11-01
AU5175779A (en) 1980-04-24
JPS6455184A (en) 1989-03-02
EP0010421A1 (en) 1980-04-30
PL218977A1 (es) 1980-06-16
GT196000041A (es) 1981-04-04
PL122756B1 (en) 1982-08-31
AR221738A1 (es) 1981-03-13
CS219259B2 (en) 1983-03-25
FI65631B (fi) 1984-02-29
CA1137900A (en) 1982-12-21
LU81794A1 (fr) 1980-05-07
DD146618A5 (de) 1981-02-18
DOP1979002809A (es) 1987-12-03
YU247079A (en) 1982-10-31
FI793190A (fi) 1980-04-17
HK42987A (en) 1987-06-05
GB2031437A (en) 1980-04-23
IE791948L (en) 1980-04-16
AT365235B (de) 1981-12-28
CH655127A5 (fr) 1986-03-27
GB2031437B (en) 1982-10-27
JPS5592353A (en) 1980-07-12
BE879401A (fr) 1980-04-15
DK148918C (da) 1986-05-12
EG14631A (en) 1985-03-31
SU1071226A3 (ru) 1984-01-30
GR73146B (es) 1984-02-10
IL58448A (en) 1983-03-31
DK148918B (da) 1985-11-18
NZ191822A (en) 1982-09-14
MY8500568A (en) 1985-12-31
DE2967701D1 (de) 1990-11-15
AU531616B2 (en) 1983-09-01
RO77097A (ro) 1981-06-22
ZA795435B (en) 1981-05-27
IL58448A0 (en) 1980-01-31

Similar Documents

Publication Publication Date Title
FI65631C (fi) Foerfarande foer framstaellning av a-21978-antibiotika
US4331594A (en) A-21978 Antibiotics and process for their production
FI79141C (fi) Foerfarande foer framstaellning av antibiotika bbm-2478a och bbm-2478b.
FI98739C (fi) Menetelmät benanomisiinien A ja B sekä deksylosyylibenanomisiinin B valmistamiseksi
USRE32333E (en) A-21978 Antibiotics and process for their production
USRE32455E (en) A-21978 antibiotics and process for their production
FI86892C (fi) Foerfarande foer framstaellning av antitumoer ll-e33288-antibioter och mikroorganismer, som producerar dessa
FI67403C (fi) Foerfarande foer framstaellning av antibiotfoereningar med antitumoereffekt
NL8501708A (nl) Antitumor antibioticum.
KOMORI et al. LAVENDOMYCIN, A NEW ANTIBIOTIC I. TAXONOMY, ISOLATION AND CHARACTERIZATION
CA1337758C (en) Peptide antibiotics
FI81114B (fi) Foerfarande foer framstaellning av antibiotika bbm-1675 a1, a2, a3, a4 och b1 och b2 med antitumoerverkan.
US5451581A (en) Antibiotic LL-14E605β and O-methyl-LL-14E605β
EP1448784B1 (en) Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
KR830001069B1 (ko) A-21978 항생제의 제조방법
CA1228313A (en) Antibiotic sb 22 484
KR860001291B1 (ko) A 53868인자 a의 제조방법
JPH01149791A (ja) 化合物ｔａｎ−９９９、その製造法および用途
US4683220A (en) Novel physiologically active substances K-26, a process for preparation thereof and a pharmaceutical composition containing the same
AU781398B2 (en) Amycomycin, a process for its production and its use as a pharmaceutical
US4482488A (en) Antibiotic A53868 and process for production thereof
JP2000239292A (ja) 抗ｍｒｓａ抗生物質
CA2110854A1 (en) Antiviral antibiotic bu-4628v and preparation thereof
JPH02142799A (ja) 新規なグリコペプチド抗生物質のデカプラニン
EP0431323A1 (en) Antitumor antibiotic BU-3983T

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ELI LILLY AND COMPANY